The global erectile dysfunction device market is anticipated to reach a valuation of US$ 1.5 billion in 2024, driven by healthcare reimbursement policies. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 9.5% between 2024 and 2034, and reaching a total valuation of approximately US$ 3.9 billion …